Are adolescents dying by suicide taking SSRI antidepressants? A review of observational studies

Australasian Psychiatry

Volumn 18, Issue 3, 2010, Pages 242-245

  Dudley, Michael ^a,b   Goldney, Robert ^c   Hadzi Pavlovic, Dusan ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Adolescent; Antidepressant; Selective serotonin reuptake inhibitors; Suicide; Young people

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG FATALITY; DYING; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREVALENCE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TIME OF DEATH; TREATMENT PLANNING;

ADOLESCENT; CAUSE OF DEATH; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DRUG UTILIZATION; FEMALE; HUMANS; MALE; POPULATION SURVEILLANCE; RISK; SEROTONIN UPTAKE INHIBITORS; STATISTICS AS TOPIC; SUICIDE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952798119     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.3109/10398561003681319     Document Type: Article

References (31)

1. Mosholder AD, Willy M. Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis. Journal of Child and Adolescent Psychopharmacology 2006; 16 : 25-32.
2. Hammad T. R esults of the Analysis of Suicidality in Pediatric Trials of Newer Antidepressants. Bethesda: Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research. Joint Meeting of the CDER Psychopharmacologic Drugs Advisory Committee and the FDA Pediatric Advisory Committee; 13 September 2004 [cited 25 September 2007.] Available from URL: http://www. fda.gov/ohrms/dockets/ac/ 04/transcripts/2004-4065T1.pdf and http://www.fda.gov/ ohrms/ dockets/ac/04/slides/2004-4065S1.htm.
3. Hammad T, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 2006; 63 : 332-339.
4. Libby A, Orton HD, Valuck R. Persistent decline in depression treatment after FDA warnings. Archives of General Psychiatry 2009; 66 : 633-639.
5. Gibbons RD, Brown CH, Hur K et al . Early evidence on the effects of regulators ' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry 2007; 164 : 1356-1363.
6. Wheeler BW, Gunnell D, Metcalfe C, Stephens P, Martin RM. The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study. British Medical Journal 2008; 336 : 542-545 (Epub 14 February 2008).
7. Kaizar EE, Greenhouse JB, Seltman H, Kelleher K. Do antidepressants cause suicidality in children? A Bayesian meta-analysis. Clinical Trials 2006; 3 : 73-98.
8. Bridge JA, Iyengar S, Salary CB et al . Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. Journal of the American Medical Association 2007; 297 : 1683-1696.
9. Dudley M, Hadzi-Pavlovic D, Andrews D, Perich T. New generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence? Australian and New Zealand Journal of Psychiatry 2008; 42 : 456-466.
10. March JS. Letter: authors of TADS study reply to letter raising concerns. British Medical Journal 2005; 330 : 730-731.
11. Brent D, Emslie G, Clarke G et al . Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. Journal of the American Medical Association 2008; 299 : 901-913.
12. Curry J, Rodhe P, Simons A. Predictors and moderators of acute outcome in the Treatment for Adolescents With Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45 : 1427-1438.
13. The TADS Team. The Treatment for Adolescents with Depression Study (TADS): longterm effectiveness and safety outcomes. Archives of General Psychiatry 2007; 64 : 1132-1144.
14. Ludwig J, Marcotte DE. Anti-depressants, suicide, and drug regulation. Journal of Policy Analysis and Management 2005; 24 : 249-272.
15. Wells KB. Treatment research at the crossroads. The scientific interface of clinical trials and effectiveness research. American Journal of Psychiatry 1999; 156 : 5-10.
16. Goldney RD. Suicide and antidepressants: what is the evidence? Australian and New Zealand Journal of Psychiatry 2006; 40 : 381-385.
17. Barbui C, Esposito E, Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ 2009; 180 : 291-297.
18. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Archives of General Psychiatry 2006; 63 : 1358-1367.
19. Søndergård L, Kvist K, Andersen P, Kessing, LL. Do antidepressants precipitate youth suicide: a national pharmacoepidemiological study. European Journal of Child and Adolescent Psychiatry 2006; 15 : 232-240.
20. Gibbons R, Mann JJ. Proper studies of selective serotonin reuptake inhibitors are needed for youth with depression. CMAJ 2009; 180 : 270-271.
21. Goldney R. S uicide Prevention. Oxford: Oxford University Press, 2008.
22. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. Journal of the American Medical Association 2004; 292 : 338-343.
23. Leon A, Marzuk P, Tardiff K, Teres J. Paroxetine, other drugs and youth suicide in New York City, 1993 through 1998. Journal of Clinical Psychiatry 2004; 65 : 915-918.
24. Isacsson G, Holmgren P, Ahlner J. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14857 suicides. Acta Psychiatrica Scandinavica 2005; 111 : 286-290.
25. Moskos M, Olson L, Halbern S, Keller T, Gray D. Utah youth suicide study: psychological autopsy. Suicide and Life Threatening Behavior 2005; 35 : 536-546.
26. Leon A, Marzuk P, Tardiff K, Bucciarelli A, Piper T, Galea S. Antidepressants and youth suicide in New York City, 1999 - 2002. Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45 : 1054-1058 .
27. Olfson M, Marcus SC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adolescents: a case-control study. Archives of General Psychiatry 2006; 63 : 865-872.
28. Shaffer D, Gould MS, Fisher P et al. Psychiatric diagnosis in child and adolescent suicide. Archives of General Psychiatry 1996; 53 : 339-348.
29. Beautrais A. Risk factors for suicide and attempted suicide among young people. Australian and New Zealand Journal of Psychiatry 2000; 34 : 420-436.
30. Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. American Journal of Psychiatry 2006; 163 : 41-47.
31. Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity adjusted retrospective cohort study. CNS Drugs 2004; 18 : 1119-1132.